type here...

CATEGORIES

Pharmaceutics

LATEST

123...11Page 2 of 11

TRENDING

EDITORS CHOICE

St. Jude scientists identify possible COVID-19 treatment in the lab

Medika Life -
If validated, the discovery by St Jude scientists could offer real tools to deal with hyperinflammatory immune responses, one of the leading causes of death in Covid-19 infections

Oxycodone No Better in Treating Post-Orthopedic Surgical Pain

Dr. Hesham A. Hassaballa -
The opioid crisis has taken the lives of thousands of people in our country. In fact, according to the CDC, opioid overdose deaths hit...

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life -
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

It’s Time to Up Our Messaging Game Ahead of Another Winter with COVID

Richard Hatzfeld -
This is not the time to roll out stale messaging delivered by a carousel of health officials trying to convince the public to get the test kits.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories